279 related articles for article (PubMed ID: 17368973)
21. Intrauterine application of progestins in hormone replacement therapy: a review.
Riphagen FE
Climacteric; 2000 Sep; 3(3):199-211. PubMed ID: 11910622
[TBL] [Abstract][Full Text] [Related]
22. Uses of progesterone in clinical practice.
Warren MP; Shantha S
Int J Fertil Womens Med; 1999; 44(2):96-103. PubMed ID: 10338267
[TBL] [Abstract][Full Text] [Related]
23. Hormonal contraception: state of the art and future perspectives.
Benagiano G; Bastianelli C; Farris M
Minerva Ginecol; 2007 Jun; 59(3):241-70. PubMed ID: 17576403
[TBL] [Abstract][Full Text] [Related]
24. [Authors' experience with transvaginal administration of progestagens].
Cataldi U; Tridente V; Pazienza S; Brizzi C; Serrao L; Proia L; Quattrini MJ
Clin Ter; 1997 Apr; 148(4):165-72. PubMed ID: 9377851
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular effects of medroxyprogesterone acetate and progesterone: a case of mistaken identity?
Hermsmeyer RK; Thompson TL; Pohost GM; Kaski JC
Nat Clin Pract Cardiovasc Med; 2008 Jul; 5(7):387-95. PubMed ID: 18521110
[TBL] [Abstract][Full Text] [Related]
26. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
Bachmann GA; Schaefers M; Uddin A; Utian WH
Menopause; 2009; 16(5):877-82. PubMed ID: 19458560
[TBL] [Abstract][Full Text] [Related]
27. Intrauterine progestins, progesterone antagonists, and receptor modulators: a review of gynecologic applications.
Rodriguez MI; Warden M; Darney PD
Am J Obstet Gynecol; 2010 May; 202(5):420-8. PubMed ID: 20031112
[TBL] [Abstract][Full Text] [Related]
28. Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study.
Sonnet E; Lacut K; Roudaut N; Mottier D; Kerlan V; Oger E
Clin Endocrinol (Oxf); 2007 May; 66(5):626-31. PubMed ID: 17492948
[TBL] [Abstract][Full Text] [Related]
29. Pharmacology of estrogens and progestogens: influence of different routes of administration.
Kuhl H
Climacteric; 2005 Aug; 8 Suppl 1():3-63. PubMed ID: 16112947
[TBL] [Abstract][Full Text] [Related]
30. New progestogens: a review of their effects in perimenopausal and postmenopausal women.
Sitruk-Ware R
Drugs Aging; 2004; 21(13):865-83. PubMed ID: 15493951
[TBL] [Abstract][Full Text] [Related]
31. Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application.
Mueck AO; Genazzani AR; Samsioe G; Vukovic-Wysocki I; Seeger H
Menopause; 2007; 14(6):978-84. PubMed ID: 17595593
[TBL] [Abstract][Full Text] [Related]
32. United States regulatory considerations for intrauterine progestins for hormone replacement therapy.
Rarick L
Contraception; 2007 Jun; 75(6 Suppl):S140-3. PubMed ID: 17531606
[TBL] [Abstract][Full Text] [Related]
33. Nanoparticle delivery for transdermal HRT.
Valenzuela P; Simon JA
Maturitas; 2012 Sep; 73(1):74-80. PubMed ID: 22325243
[TBL] [Abstract][Full Text] [Related]
34. Postmenopausal hormone therapy and the risk of breast cancer: a contrary thought.
Speroff L
Menopause; 2008; 15(2):393-400. PubMed ID: 17925662
[TBL] [Abstract][Full Text] [Related]
35. Steroid releasing vaginal rings.
Nuttal ID; Elstein M
Acta Eur Fertil; 1980 Sep; 11(3):225-30. PubMed ID: 6781195
[TBL] [Abstract][Full Text] [Related]
36. Estrogen replacement therapy in combination with continuous intrauterine progestin administration reduces the amount of circulating oxidized LDL in postmenopausal women: dependence on the dose of progestin.
Ahotupa M; Rauramo I; Vasankari TJ; Skouby SO; Hakonen T
Ann Med; 2004; 36(4):278-84. PubMed ID: 15224654
[TBL] [Abstract][Full Text] [Related]
37. Progesterone: review of safety for clinical studies.
Goletiani NV; Keith DR; Gorsky SJ
Exp Clin Psychopharmacol; 2007 Oct; 15(5):427-44. PubMed ID: 17924777
[TBL] [Abstract][Full Text] [Related]
38. Postmenopausal hormone replacement therapy--advancement in drug delivery system.
Bhattacharya SK
J Indian Med Assoc; 1995 Oct; 93(10):370-1, 374. PubMed ID: 9053407
[No Abstract] [Full Text] [Related]
39. The impact of micronized progesterone on the endometrium: a systematic review.
Stute P; Neulen J; Wildt L
Climacteric; 2016 Aug; 19(4):316-28. PubMed ID: 27277331
[TBL] [Abstract][Full Text] [Related]
40. [Clinical relevance of drug interactions between sexual steroids and other medications].
Mueck AO; Römer T
Zentralbl Gynakol; 2000; 122(3):141-9. PubMed ID: 10756597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
